Pluri Inc. stock is down -14.47% since 30 days ago. The next earnings date is Sep 12, 2023. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 47.62% of the previous 20 December’s closed higher than November.
Pluristem Therapeutics Inc. focuses on the research, development, clinical trial, and manufacture of cell therapeutic products and related technologies. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trial for the recovery after surgery for hip fracture.